SuperCells (SCT) and BNB (BNB) compared side by side. Over the past 1 year, BNB is ahead by 56.2 percentage points (SCT -85.9% against BNB -29.7%). Their daily returns move barely together (correlation 0.20 across 363 shared trading days). SCT has been the more volatile of the two, at 246% annualised against BNB's 51%.
SCTBNB
0.20over 363 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | SCT | BNB |
|---|---|---|
| Max drawdown (400d) | -95.7% | -58.2% |
| Risk-adjusted return (90d) | -0.39 | 0.45 |
| Best 30 days (past year) | — | +29.4% |
| Worst 30 days (past year) | — | -34.9% |
Relative strength over 90 days: BNB outperformed SCT by 90.1% — measured on the SCT/BNB ratio, so it holds regardless of market direction.